AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,125,000 | +152.6% | 150,000 | +66.7% | 0.65% | +121.1% |
| Q1 2015 | $2,821,000 | +9.2% | 90,000 | +1.7% | 0.29% | -33.2% |
| Q4 2014 | $2,584,000 | -23.6% | 88,516 | -45.9% | 0.44% | +5.3% |
| Q3 2014 | $3,383,000 | +24.1% | 163,516 | +48.7% | 0.42% | -37.8% |
| Q2 2014 | $2,725,000 | +14.3% | 110,000 | -2.2% | 0.67% | +23.5% |
| Q1 2014 | $2,384,000 | +20.6% | 112,500 | +2.3% | 0.54% | -1.1% |
| Q4 2013 | $1,976,000 | – | 110,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |